Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway
Liwen Chen(Guiyang Medical University), Chengyi Sun(Guiyang Medical University)
Cited by 33
Related Papers
LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway
|Cell Death and Disease|2019|185
MicroRNA-137 reduces stemness features of pancreatic cancer cells by targeting KLF12
|Journal of Experimental & Clinical Cancer Research|2019|71